DUBLIN--(BUSINESS WIRE)--The "Breast Implants Market - Global Outlook & Forecast 2023-2028" report has been added to ResearchAndMarkets.com's offering.
The Global breast implants market is forecast to reach a value of $3,793.71 million by 2028 from $2,529.33 million in 2022, growing at a CAGR of 6.9%. The rapid acceptance of minimally invasive breast augmentation is anticipated to provide significant growth to the market.
The emergence of under-the-muscle (armpit) breast enlargement, also called transaxillary breast augmentation, has revolutionized the breast implants market as the scar is not visible in these procedures and is thus considered a minimally invasive procedure. In recent years, transaxillary breast augmentation has grown and is gaining popularity. The growing popularity of transaxillary breast augmentation procedures can be attributed to a lower risk of scarring.
Increasing Prevalence of Breast Cancer
Breast cancer continues to be the most common cancer among females worldwide. The rising number of breast cancer cases fosters the growth of implant-based breast reconstruction procedures. According to the GLOBOCAN 2020 survey, in India alone, the breast cancer rate has reached almost 13.5%.
Countries like Indonesia, Singapore, and Malaysia have the highest breast cancer death rates. The rate of mastectomy in the APAC region is rising due to many breast cancer cases. Hence, the rising mastectomy rate in the region is driving the breast implant market.
Growing Demand for Cosmetic Surgeries
The growing social and cultural influences such as the media, film industry, peer pressure for appearance and attractiveness, and shifting dimensions of beauty are driving the breast implants market growth. They have raised the number of cosmetic surgery hospitals worldwide.
For instance, in 2020, USD 16.7 billion was spent on cosmetic procedures in the US, according to ASPS. The use of social media and social networks are part of modern life, and they have contributed to making women aware of trending cosmetic surgeries. More people are using these online channels to get information regarding health procedures and surgeries. Thus, with the rise of social media, the growth of the cosmetic surgery industry is fostered.
SEGMENTATION INSIGHTS
INSIGHTS BY PRODUCT
The silicone segment accounted for the largest revenue share of 81.96% in 2022 and is expected to grow at a CAGR of 7.27% in the global breast implants market.
The silicone implant's larger share can be attributed to its soft and natural texture, like natural breast tissues. Recent advancement in silicone implants is gummy bear implants. A gummy bear silicone implant offers a more natural shape to the reconstructed breast and is safer than traditional ones.
The silicone implant segment does not pose a risk for disorders linked with the immune system. Due to this feature, hard scar tissue formation is less likely around the implantation. In the US, all silicone implants are made of cohesive gel, a thicker type of silicone implant.
Saline breast implants are also expected to witness significant growth during the forecast period owing to fewer complications or risks associated with this type during implant rupture. The global saline breast implants market was valued at USD 456.17 million in 2022. As saline breast implants are more easily seen under the skin and make feel water sloshing, the adoption of saline breast implants is comparatively very low. However, it is still preferred by many women in many countries because of its low cost.
INSIGHTS BY SHAPE
The round segment accounted for the highest revenue share of 81.96% in 2022 owing to its fuller and voluminous look and ideal for breast augmentation in the global breast implants market. However, anatomical implants are expected to grow faster, with a CAGR of 9.48% during the forecast period, because it attains the natural shape of breasts and is recommended for women who lack breast tissue or are smaller-built or prefer more natural teardrop-shaped breasts and are also highly preferred for breast reconstructive surgeries.
INSIGHTS BY SURFACE
Smooth breast implant accounted for the highest revenue share in the global breast implants market and is also expected to grow at the highest CAGR of 7.72% during the forecast period. Smooth breast implants are the more popular choice as they last longer than textured implants and have less risk of rippling and leaking. Many plastic surgeons thus prefer to use smooth implants. Moreover, smooth implants are also considered safe and have not shown any association with cancer.
In contrast, textured implants highly associated with breast implant-associated cancer are expected to decline with a CAGR of 12.93% during the forecast period. Textured implants from one of its leading manufacturers, Allergan (AbbVie), have been completely recalled in 2019 globally and are thus the least preferred by plastic surgeons.
Textured implants develop scar tissue to stick to the implant, making them less likely to move around breast tissues and become relocated or reshifted. It could be either round or teardrop shape. Eardrop-shaped implants require a textured shell because the texture helps it adhere to the breast tissue.
INSIGHTS BY APPLICATION
Breast augmentation dominates the global breast implants market. Compared to breast reconstructive procedures, the demand for breast augmentation procedures is gaining popularity as they improve saggy breasts among aged women and enlarge breasts among young women to enhance their beautiful appearance.
Breast augmentation is expected to grow at the highest CAGR of 7.40% during the forecast period as the demand continues to rise among young women aged 20-35. Emerging economies such as Brazil, Mexico, and India hold significant opportunities for players in breast augmentation procedures. The demand for breast augmentation procedures in these nations is increasing due to rapid growth in medical tourism and increasing disposable incomes.
The global breast reconstruction market was valued at USD 567.06 million in 2022 and is expected to grow impressively by 2028. Breast reconstruction is commonly performed on women who are receiving mastectomy. As of 2016, more than 40% of women in the US who underwent mastectomy had reconstruction.
According to the ASPS, approximately 101,600 women in the US underwent breast reconstruction in 2018. In the US, immediate reconstruction is the most common practice, selected for about 75% of patients. The rising mastectomy procedures and the increasing prevalence of breast cancer are driving the growth of the breast implants market.
INSIGHTS BY END-USER
The hospital segment accounted for the largest end-user share in the breast implants market, owing to surgeons' increasing preference for hospital treatment. According to the ISAPS report, about 43.80% of cosmetic procedures were performed in hospitals alone, followed by cosmetology clinics (32.40%), and in others (ambulatory care settings and academic institutes), about 23.8% of cosmetic procedures in 2020.
However, cosmetology clinics are expected to grow at the highest CAGR of 7.44% owing to their better convenience, less crowd, discounted price/low cost, and trained and experienced cosmetic surgeons. The youth, especially millennials and Generation Z, have more disposable income to spend on their looks and grooming.
Moreover, with the surge in the usage of social media platforms worldwide, the popularity of cosmetic surgeries in cosmetology clinics has increased. Due to this, compared to 2018, the share of cosmetology clinics for cosmetic surgeries spiked and showed 18.37% in 2020.
VENDOR LANDSCAPE
The global breast implants market is a duopoly, highly dynamic, and moderately competitive, with several international, regional, and local vendors that offer a diverse and comprehensive range of breast implants with applications in breast augmentation and reconstruction procedures.
Companies that hold duopoly positions are AbbVie and Johnson & Johnson. Other key companies are most likely to compete equally with the top two leading companies, AbbVie, and Johnson & Johnson, in the coming years. The market is witnessing a surge in innovations and investments in the development of breast implants, and new entrants can be witnessed during the forecast period. There is also a surge in product launches in recent years.
This market's competition is expected to strengthen during the forecast period. Leading players have a wide range of product portfolios in both applications. Expansion activities help vendors to strengthen their global distribution networks, which allows players to explore untapped opportunities. Large-scale investments and funding in the global breast implants market through varied conglomerates and investment firms allow product development.
Further, mergers and acquisitions play a key role in the smooth functioning of companies' growth. Global players are expected to increase their footprints in the market, especially in terms of quality, features, and price.
Market Opportunities & Trends
- Growth in Demand for Gummy Bear Implants
- Technological Advances in Breast Implants
- Increase in Popularity of Minimally Invasive Procedures
Market Growth Enablers
- Growing Demand for Breast Augmentation Procedures
- Increasing Prevalence of Breast Cancer
- Growing Demand for Cosmetic Surgeries
Market Restraints
- Complications Associated With Breast Implants
- High Cost of Breast Augmentation Procedures
- Increase in Product Recalls
Key Company Profiles
- AbbVie
- Johnson & Johnson
Key Companies To Watch
- Sientra
- Establishment Labs
- POLYTECH Health & Aesthetics
- GC Aesthetics
Other Prominent Vendors
- Hans Biomed
- IDEAL IMPLANT
- Laboratoires Arion
- Sebbin
- Silimed
For more information about this report visit https://www.researchandmarkets.com/r/tgr2hg-implants?w=4
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
